Next Article in Journal
Characterisation of Dry-Salted Violino and Bresaola from Grass-Fed Bergamasca Sheep
Previous Article in Journal
Three-Way k-Means Model: Dynamic Optimal Sensor Placement for Efficient Environment Monitoring in Pig House
Previous Article in Special Issue
Effects of Antimicrobial Administration Route on Growth and Antimicrobial Resistance in Weaned Piglets
 
 
Font Type:
Arial Georgia Verdana
Font Size:
Aa Aa Aa
Line Spacing:
Column Width:
Background:
Article

Characterization of Antimicrobial Resistance in Escherichia coli Isolated from Diarrheic and Healthy Weaned Pigs in Catalonia

Department Sanitat i Anatomia Animals, Veterinary School, Universitat Autonoma de Barcelona, 08193 Cerdanyola del Valles, Spain
*
Authors to whom correspondence should be addressed.
Submission received: 16 December 2023 / Revised: 11 January 2024 / Accepted: 30 January 2024 / Published: 1 February 2024

Abstract

:

Simple Summary

Postweaning diarrhea (PWD) is a significant concern in the swine industry, causing substantial economic losses due to decreased growth rates, increased mortality, and the extensive use of antimicrobials. Certain Escherichia coli (E. coli) pathovars are frequently implicated in PWD cases among piglets. Regular surveillance and testing of E. coli susceptibility to different antimicrobials is essential. This helps veterinarians and farmers select appropriate treatments, avoid unnecessary antibiotic use, and prevent the further spread of antimicrobial resistance (AMR). Herein, we tested the susceptibility to fourteen antimicrobials of 251 E. coli strains isolated from fecal samples of diarrheic (n = 148) and apparently healthy piglets (n = 103) in farms in Catalonia. The results of this study showed that 41.4% of the E. coli were multidrug-resistant (MDR) strains, presenting high resistance to conventional veterinary antimicrobials such as erythromycin, amoxicillin, streptomycin, tetracycline, lincospectin, sulfamethoxazole/trimethoprim, and florfenicol. A special concern was also observed for human last-resort antimicrobials, like quinolones and colistin. Moreover, pigs suffering from diarrhea had a higher frequency of infection with MDR strains than the healthy ones. To reduce the incidence and impact of PWD in pig herds, optimization of antimicrobial therapies had to be implemented with other strategies, such as good hygiene practices, optimizing nutrition, managing stress levels, and employing proper vaccination protocols.

Abstract

Postweaning diarrhea (PWD) is a multifactorial concern in the swine industry that leads to high antibiotic consumption, usually without testing susceptibility, increasing the risk of the selection of Escherichia coli-resistant strains. In this study, 251 E. coli strains isolated from fecal samples of diarrheic (n = 148) and apparently healthy piglets (n = 103) in farms in Catalonia were tested against their susceptibility to fourteen different antimicrobials. The phenotypic antimicrobial resistance (AMR) testing revealed high levels of AMR, with 41.4% of the isolates presenting a multidrug-resistant (MDR) profile. More specifically, resistance to class D (prudence) antimicrobials such as erythromycin (99.6%), amoxicillin (95.2%), streptomycin (91.6%), tetracycline (88.8%), lincospectin (64.5%), and sulfamethoxazole/trimethoprim (60%) was very high, as well as to class C (caution) antimicrobials such as florfenicol (45%). A special concern was observed for antimicrobial category B (restrict), like quinolones and colistin, that both presented a high rate of resistance. Colistin use was substantially reduced in Spain, but resistance is still present in weaned pigs, presenting a MIC90 of 4 μg/mL. This suggests that reducing antibiotic use is not enough to eliminate this AMR. Finally, it was found that piglets suffering diarrhea were more commonly carriers of MDR strains than the healthy ones (49.3% vs. 35%, p = 0.031). Therefore, given the high rates of resistance to the most commonly used antimicrobials, especially in diseased pigs, a new non-antibiotic-based approach should be implemented for the management of PWD.

1. Introduction

In natural conditions, piglets are weaned in a gradual way at 12 weeks of life [1]. However, intensive productive conditions in the swine industry are quite different since animals are early-weaned at 3–4 weeks, when their intestines and immune system have not matured yet. This circumstance represents a stressful situation for the young animals, which leads them to anorexia that can last for even 48 h, with associated intestinal inflammation [2]. Moreover, stress generates an immunosuppressive state, which makes pigs susceptible to infectious agents [3]. Finally, the sudden change from a liquid to a solid diet leads to changes in the microbiota composition and diversity, which, although not fully understood, make piglets more susceptible to PWD [4].
Adding more complexity to the problem, postweaning diarrhea (PWD) has a multifactorial etiology. Escherichia coli (E. coli) is the main bacteria implicated in the process, with different virulence factors implicated, such as fimbriae F4 and F18, thermostable (STa, STb) and thermolabile (LT) toxins, verotoxins (VT1 and VT2), or the gene that encodes for intimin eae [5]. However, previous research on the role of E. coli as a main pathogen in the development of diarrhea reported nonconclusive results [6]. Viral infections are also commonly related to intestinal disorders, especially those caused by Rotavirus A, B, and C [7], as well as coronaviruses such as the porcine epidemic diarrhea virus or transmissible gastroenteritis virus. All these viruses have been identified as primary enteric pathogens [6,8,9]. On the other hand, non-infectious causes like nutrition, bad husbandry practices, or any stressful situation could lead to the development of PWD [10]. Furthermore, various factors can coexist simultaneously, making PWD a complex and multifactorial concern. In consequence, identifying a precise cause or origin can pose significant challenges. Nevertheless, young animals find themselves in a particularly vulnerable state, prompting the implementation of antimicrobial treatments, even in cases where a bacterial cause has not been definitively confirmed as the etiological agent.
As already expected by Alexander Fleming, antimicrobial use over the years has led to the apparition of antimicrobial resistance (AMR) bacteria. This has been specifically proven in swine production [11,12], and principally, it has been shown that AMR levels were significantly high at the weaning phase [13]. Reduced effectiveness of antimicrobial agents may lead to higher mortality rates from bacterial infections, posing a threat to animal well-being and causing significant economic losses. Moreover, AMR has become an important cause of death in humans [14]. But, although an epidemiological link has been found [15], livestock contribution to human AMR remains unclear since this relationship seems not to be present at the genomic level [16,17]. However, transmission of AMR genes via plasmids from livestock to humans has been proven [18], and it has been shown that people in close contact with farms have a higher risk of certain AMR bacteria, such as methicillin-resistant Staphylococcus aureus [19,20], and those bacteria are carriers of more AMR genes [21]. Therefore, AMR bacteria in livestock should be considered a public health threat, especially for farm and slaughterhouse workers.
The European Medicines Agency (EMA) categorizes antimicrobials used in veterinary medicine into different categories based on their importance, intended use, and impact on antimicrobial resistance [22]. These categories are designed to guide veterinarians and stakeholders in the responsible use of these medications, determining which antimicrobials veterinarians can use as first-line treatments and those that should be avoided or restricted. Category A (avoid) includes antimicrobials that are deemed critically important for human medicine and are not authorized for veterinary use (i.e., carbapenems). Category B (restrict) includes antimicrobials considered important for human medicine and should be used in animals with great caution and only when no suitable alternatives are available and when they are based on antimicrobial susceptibility testing (i.e., 3rd and 4th generation cephalosporins, quinolones, and polymyxins). In categories C (caution) or D (prudence), antimicrobials like the 1st generation of cephalosporins, aminoglycosides, chloramphenicol, penicillin/β-lactam inhibitors, tetracyclines, and trimethoprim/sulfonamides are included. These antimicrobials are considered acceptable and authorized for veterinary use as initial treatments for bacterial infections. It is important to follow these guidelines to prevent antibiotic resistance and ensure the responsible use of antimicrobials in veterinary medicine.
The study of AMR in livestock is indeed crucial. Techniques like whole-genome sequencing (WGS) of bacterial genomes and metagenomics play a significant role in identifying and understanding AMR determinants and transmission routes in various bacterial populations [23,24]. However, despite these advanced techniques, there are instances, as in the case of porcine E. coli, where phenotypical susceptibility analyses remain essential. This is especially important in PWD, where animals often require prompt antibiotic treatment before the availability of bacteriological diagnosis and antibiotic susceptibility test results. Therefore, field studies are crucial in creating adequate guidelines to help veterinary practitioners use antimicrobials in ways that prioritize animal health while minimizing the risk of antimicrobial resistance development.
In the present study, E. coli strains isolated from farms experiencing PWD in Catalonia, an area known for high pig production, were analyzed to understand the antibiotic susceptibility patterns. Moreover, this study aimed to investigate whether there are distinct antimicrobial susceptibility phenotype patterns in E. coli strains associated with PWD in diarrheic piglets compared to those found in healthy animals within the same environment.

2. Materials and Methods

2.1. Bacterial Identification

E. coli strains were isolated from 17 pig farms (14 farms with active and recurrent PWD outbreaks and 3 farms with sporadic PWD outbreaks in the last 12 months) between February 2020 and December 2021. All the studied farms were distributed in Catalonia (NE of Spain), the Spanish region with the greatest number of intensive production farms and one of the highest pig-density regions in Europe. A total of 251 fecal samples were collected from 3- to 5-week-old piglets; 148 out of them were diarrheic animals, and 103 were healthy pen mates that were considered healthy controls.
One gram of fresh stool samples was obtained directly from the animals using sterile rectal swabs. Swab samples were transported on Amies transport medium (Deltalab, Rubí, Spain) and submitted for diagnostic testing to the Veterinary Infectious Diseases Diagnostic Laboratory of the Autonomous University of Barcelona (UAB) (Bellaterra, Spain). All samples were cultured in Columbia blood agar (BD GmBh, Heidelberg, Germany) and MacConkey agar (Oxoid, Basingstoke, UK) and incubated for 24 h at 37 °C. Suspected colonies were identified using conventional biochemical tests (oxidase, catalase, TSI, SIM, urease, citrate, and methyl red) or Api System® (bioMérieux, Marcy l’Etoile, France).

2.2. Antimicrobial Susceptibility Testing

A Kirby–Bauer disk diffusion susceptibility test protocol [25] was used to determine the phenotypic antimicrobial susceptibility of E. coli isolates. Briefly, colonies were suspended in 5 mL of distilled, sterile water to achieve a turbidity of 0.5 on the McFarland scale. The dilution was then seeded onto Mueller–Hinton (Oxoid, UK) plates. Each isolate was tested for the following antimicrobial groups using commercial disks (Oxoid, UK): aminopenicillins (amoxicillin 25 μg and amoxicillin/clavulanic acid 20 μg/10 μg); cephalosporins (ceftiofur 30 μg, cephalexin 30 μg); carbapenems (imipenem 10 μg); quinolones (enrofloxacin 5 μg); aminoglycosides (gentamicin 10 μg, streptomycin 10 μg); macrolides (erythromycin 15 μg) tetracyclines (tetracycline 30 μg); sulfonamides (sulfamethoxazole/trimethoprim 23.75 μg/1.25 μg); florfenicol (30 μg); and lincospectin (2 μg).
Additionally, a minimum inhibitory concentration (MIC) test was performed to evaluate antimicrobial susceptibility to colistin using the broth microdilution method in 96-well plates [26]. E. coli ATCC 25922 was used as the quality control strain. Briefly, the tested colistin concentrations ranged from 0.25 to 8 μg/mL. The studied strains were considered resistant when their MIC value was higher than the wild-type cut-off value, which was at MIC > 2 μg/mL [27]. MIC50 and MIC90 were considered the median and percentile 90 of the population, respectively.
The susceptibility of bacteria to each antimicrobial agent was interpreted as susceptible (S), intermediate (I), and resistant (R) based on the breakpoints provided by the Clinical & Laboratory Standards Institute (CLSI) and the European Committee on Antimicrobial Susceptibility Testing (EUCAST). CLSI veterinary breakpoints were preferably used [28], and when not available, CLSI human [29], EUCAST, or CASFM veterinary breakpoints were applied as previously published by Vidal et al. [30]. In addition, multidrug resistance (MDR) was defined as resistance to at least one agent in ≥3 antimicrobial categories according to the Magiorakos et al. classification [31].

2.3. Statistical Analysis

Chi-squared or Fisher exact tests were used for comparison between proportions when appropriate. These statistical tests, employed to scrutinize differences in proportions, were complemented with visualizations created using R (version 4.2.1) [32] with the ggplot2 package [33]. The threshold for establishing statistical significance was set at a p-value of less than 0.05.

3. Results

3.1. Antimicrobial Susceptibility Testing

Antibiotic susceptibility testing was performed on 251 E. coli isolates: 148 were from PWD-diseased pigs and 103 were from healthy pen mates. In general, levels of AMR were high, presenting 104 out of 251 isolates (41.4%) with a multidrug resistance (MDR) profile.
Most of the E. coli strains presented high levels of resistance to antimicrobials commonly used in veterinary medicine. Results are presented in Table 1.
For class D antimicrobials, AMR was broadly observed to affect erythromycin (99.6%), amoxicillin (95.2%), streptomycin (91.6%), tetracycline (88.8%), lincospectin (64.5%), and sulfamethoxazole/trimethoprim (60%). For class C antimicrobials, it is interesting to note that more than 45% of the isolates showed resistance to florfenicol (Figure 1). However, of particular concern were the resistance levels within class B antimicrobials, with over half of the isolates demonstrating resistance to quinolones, particularly against enrofloxacin (56.7%). In contrast, AMR was demonstrated to be relatively lower for certain antimicrobials, such as cephalexin with 35.1% of resistance, gentamycin with 33.5%, and amoxicillin clavulanic acid with 30.7%. Additionally, the observed levels of AMR against other class B antimicrobials like colistin were notably low at 15%, and ceftiofur exhibited a resistance rate of 26.7%. Furthermore, no instances of resistance were detected for class A carbapenems, underlining their efficacy within this bacterial population (Figure 1).

3.2. Comparison between Diarrheic Pigs and Healthy Pen Mates

The comparison analyses between isolates from diseased and healthy pigs showed that diarrheic animals were carriers of a higher percentage of MDR bacteria compared to apparently healthy piglets (49.3% vs. 35%, p = 0.031). Specific differences for each antibiotic and animal group are shown in Figure 2.
In general, AMR was quite similar between both groups, with the exception of some antimicrobials such as cephalexin, ceftiofur, lincospectin, and colistin, whose resistance levels seemed more prevalent in diarrheic pigs. However, statistical differences were only observed for the cephalexin, where diarrheic animals had higher frequencies of resistance than the healthy ones (47.7% vs. 15.9%, p = 0.003).
Finally, given its importance in human medicine and the implementation of reduction use programs [34], colistin results from the qualitative MIC method were considered for the analysis to understand its epidemiology, as the disk diffusion method has been described as not reliable when testing polymyxin E (colistin) susceptibility. The MIC results showed that most of the isolates were susceptible to colistin (84.5%). A particular focus was put on MIC50 and MIC90 to provide a better understanding of colistin activity (Figure 3A). Thus, MIC50 was stablished at 1 μg/mL, which means that the median of E. coli isolates was sensible to colistin. However, MIC90 was 4 μg/mL, which, according to EUCAST, is considered a resistance profile.
Indeed, comparing diarrheic versus healthy animals, it was observed in the density plot (Figure 3B) that diarrheic animals were carriers of more resistant E. coli strains than their healthy pen mates. Despite the MIC50 being equal for both groups (1 μg/mL), the MIC90 was significantly different, with diarrheic animals presenting a higher concentration (4 μg/mL) than control healthy pigs (2 μg/mL) (p < 0.05).

4. Discussion

The goal of this study was to characterize the antimicrobial susceptibility pattern of 251 E. coli strains obtained from weaned pigs originating from farms experiencing postweaning diarrhea (PWD) and to compare the AMR patterns between pigs suffering from diarrhea and their apparently healthy pen mates.
Despite weaning being a hotspot of antimicrobial consumption, projects analyzing AMR in E. coli strains are usually not focused exclusively on this phase but also include other productive stages [35,36,37,38,39]. This is not criticizable at all, but given the peculiarity of weaning, a stop needs to be put there. A study from Korea [13] found high levels of AMR, very similar to those found in this study, but differed from another conducted in Australia between 1999 and 2005 [40], where levels were quite lower, showing that the extrapolation of results is not advisable in all cases.
The most remarkable findings were that 41.4% of the isolates presented an MDR profile, showing elevated resistance not only to antibiotics typically used in veterinary medicine (classified as D and C categories) but also to critical human last-resort antibiotics such as quinolones and colistin. Moreover, this high prevalence of MDR isolates, coupled with a higher MIC90 for colistin, was notably more prevalent among pigs suffering from diarrhea compared to their healthy pen mates. This discrepancy highlights a concerning correlation between disease status and the prevalence of multidrug-resistant strains, especially with higher resistance to critical antibiotics in diarrheic pigs. This would mean that the therapeutic options to treat PWD are limited. This reality should make swine practitioners aware of the need to ask for antibiotic susceptibility tests before starting antimicrobial treatments. Likewise, since weaning is the swine production phase with the highest antibiotic consumption [41], it should be convenient to overcome the antibiotic mental mark and start to fight PWD with alternatives aiming at reducing the stress derived from weaning [3], focusing on animal welfare, optimizing nutrition [42], enhancing preventive measures via cleaning and disinfection [43], employing proper vaccination protocols [44], probiotic complements [45], or other alternatives such as bacteriophages [46]. Moreover, since other pathogens, such as rotaviruses or coronaviruses, have been proven to play a role in the presentation of the PWD disease [47,48], the control of concomitant infectious diseases should be strongly emphasized along with the previously mentioned measures of biosecurity and immunological prophylaxis.
As mentioned above, the levels of resistance of E. coli isolates to class D antimicrobials (those recommended to use as first choice) were high in this study. Especially remarkable was the resistance to tetracycline (88.8%), which is the most used antibiotic in pig production in Spain [49]. The overuse of tetracycline could explain this high level of resistance and should make veterinarians rethink its use to deal with PWD, given its lack of efficacy. Other class D antimicrobials, such as amoxicillin (95.2%) or streptomycin (91.6%), were practically ineffective for treating these E. coli PWD-related strains. This finding is not surprising since blaEC and blaTEM-1B (which confer resistance to amoxicillin) and strA and strB (which make isolates resistant to streptomycin) were the most common AMR genes found in porcine E. coli strains [50,51].
The isolates in this study also showed relatively high resistance to class C antimicrobials. It was expected for macrolides, such as erythromycin, because the mdf(A) gene, which confers resistance to macrolides, is fixed on the E. coli chromosome [52]. However, the levels of resistance to florfenicol (45%) are worrying since it is the only phenicol licensed for the treatment of bacterial infections in food-producing animals. In contrast, other options in this category, such as amoxicillin clavulanic acid (30.7%), cephalexin (35.1%), or gentamycin (33.5%), could be better options because the levels of AMR are below 40%. However, the resistance rates are not negligible, and, again, we need to consider different options to preserve their effectiveness.
In the situation within category B, particularly concerning were the quinolones, where over half of the isolates (56.7%) exhibited resistance to enrofloxacin. This high level of resistance to quinolones raises significant concerns due to the importance of these antimicrobials in veterinary medicine. A recently published metanalysis [53] revealed Spain to have the highest recorded resistance rates, ranging between 9% and 14%. These numbers, although significant, were notably lower compared to the resistance rates uncovered in our study. This discrepancy highlights the heightened levels of resistance observed in our specific research context, underscoring the urgency for further investigation and strategic measures to address and manage antimicrobial resistance in this setting.
Resistance to other class B antimicrobials, such as third-generation cephalosporins (26.7%) and colistin (15%), was present. The dynamics of human–livestock transmission have been explored, revealing two different paradigms. In the case of ESBL bacteria (those that are resistant to third-generation cephalosporins), differences between lower- and middle-income countries (LMICs) and developed countries have been detected. While in LMICs, the bacterial interchange between human and livestock isolates is common [47], in developed countries, the transmission of these bacteria between pig farm environments and the general human population is less frequent [16,17]. However, the scenario shifts when considering colistin. The emergence of mcr-1 in humans was notably associated with livestock, particularly swine, and aquaculture [54]. For this reason, we decided to analyze thoroughly the colistin resistance levels and calculate the minimum inhibitory concentration (MIC), revealing a concerning MIC90 of 4 μg/mL, with some isolates demonstrating even higher MIC values of 12 μg/mL. Despite the implementation of the REDUCE program, which significantly curbed colistin usage in Spain [55], our observations revealed that colistin resistance had not been eradicated. This fact could agree with Ogunlana et al. [56], who found that certain mutations in the promotor region of the mcr-1 gene could reduce its fitness cost, showing that antibiotic reduction could not be enough by itself to eliminate this specific resistance. Thus, the persistence of colistin resistance poses a challenge, indicating that despite efforts to reduce its use, resistance to this critical antibiotic remains an ongoing concern.
Finally, none of the tested E. coli isolates in this study displayed AMR to carbapenems, a class A antibiotic. This situation was expected because carbapenems are not used in swine production. However, despite their non-use in this context, reports of both phenotypical [57] and genotypical [58,59] resistance to these compounds in other regions worldwide require ongoing surveillance. Maintaining vigilant monitoring is crucial to track any potential emergence or spread of carbapenem resistance, despite their absence from swine production practices, and to proactively address any future challenges related to these critically important antimicrobials.
Overall, the levels of AMR were high in both pig groups, diseased and apparently healthy, suggesting that years of exposure to high antimicrobial pressure in pig farms might have contributed to this scenario. However, in our analysis of the comparison between levels of resistance among diarrheic and healthy animals, the ratio of multidrug-resistant (MDR) strains was notably higher in diseased piglets compared to their apparently healthy pen-mates. Specifically, significant differences were observed concerning cephalexin resistance, mirroring trends observed in human studies [60]. In the specific case of swine, cephalexin is commercialized via injectable solution, which ensures that only animals showing clinical symptoms are treated. In a related study focused on neonatal diarrhea within the same area [30], E. coli strains isolated from diarrheic animals also exhibited significantly higher resistance levels. However, the specific antimicrobials displaying resistance differed (such as quinolones and gentamicin) from our findings. Once again, these antimicrobials were predominantly available as injectable solutions. This parallel suggests a potential association warranting further investigation. However, the evidence linking the mode of antibiotic availability and resistance is not definitive and demands in-depth scrutiny for conclusive insights.
The analysis of the minimum inhibitory concentration for colistin revealed a higher MIC90 in diarrheic animals, and it is possible that this situation could be the same for other antimicrobials. It is important to note that when antimicrobials are administered through water or feed, sick animals typically reduce their consumption. Consequently, this reduction might result in lower antibiotic concentrations, leading to treatment failure as the MIC required for efficacy is not reached. This situation raises significant concerns as it suggests that the strains causing health issues might be more resilient to treatment, posing challenges to effectively addressing diseases. This discovery necessitates a comprehensive investigation, since, to our current knowledge, differences between healthy and diseased pigs during the weaning phase have not been extensively explored. Understanding these nuances in antibiotic administration and their correlation with resistance among healthy and diseased animals is pivotal for designing effective treatment strategies in pig farming contexts.
Despite this study providing a better understanding of AMR at the weaning phase, it also presents some limitations. First, this study was based on the samples submitted for diagnosis, and no representative sampling was performed, so the results are not fully extrapolated to all the territories. Second, despite the phenotype being what matters clinically, to characterize the public health risk, it is important to know the genotype, and it would be important to use other techniques such as WGS to identify the AMR responsible for the lack of effectiveness of the antibiotics. Finally, regarding the comparison between apparently healthy and diarrheic piglets, it is important to note that this condition was from a specific moment and could have changed a posteriori, but no longitudinal study was performed, so apparently healthy animals could have become diseased in the following days.
This study revealed a concerning prevalence of AMR in E. coli isolates, particularly in pigs suffering from diarrhea. This emphasizes that conventional antimicrobial therapy might not be as effective, highlighting the necessity of exploring alternative strategies. Implementing comprehensive measures such as stringent hygiene practices, optimizing nutritional regimens, managing stress levels, and deploying appropriate vaccination protocols becomes imperative in addressing this issue. This holistic approach aims to mitigate the reliance on antimicrobials alone, fostering a multi-faceted strategy to combat bacterial infections and AMR in pig populations.

5. Conclusions

This study identified high levels of AMR in PWD E. coli strains, with 41.4% notably being classified as multidrug-resistant strains. Moreover, it was evident that diarrheic animals harbored a greater prevalence of resistant E. coli strains compared to their healthy pen mates. Antimicrobials categorized under classes D and C displayed diminished effectiveness, indicating that relying solely on antibiotic treatment for PWD is inadequate. Additionally, resistance to other class B antimicrobials, such as third-generation cephalosporins and colistin, was observed, emphasizing that efforts solely focused on reducing antibiotic use may not suffice. The findings underscore the urgent need to explore new strategies and alternatives to effectively mitigate antimicrobial resistance.

Author Contributions

Conceptualization, B.G., M.M. and L.D.; methodology, B.G., M.M. and L.D.; formal analysis, B.G.; investigation, B.G.; resources, M.M. and L.D.; data curation, B.G.; writing—original draft preparation, B.G.; writing—review and editing, M.M. and L.D.; supervision, M.M. and L.D.; project administration, L.D.; funding acquisition, L.D. All authors have read and agreed to the published version of the manuscript.

Funding

BG was supported by the Departament de Recerca i Universitats de la Generalitat de Catalunya (FI-SDUR 2020). This study was funded by the I+D+I National Program RTI2018-095586-B-C22 for the project ‘Optimization of diagnosis and treatment of post-weaning diarrhea in pigs: towards a rational use of antibiotics’.

Institutional Review Board Statement

The samples were provided by field veterinarians, who took them for diagnostic purposes and did not cause any harm or suffering to any animals.

Informed Consent Statement

Not applicable.

Data Availability Statement

Data will be made available upon reasonable request to the corresponding author.

Acknowledgments

We kindly acknowledge all the field veterinarians that sent samples to our laboratory for diagnosis.

Conflicts of Interest

The authors declare no conflicts of interest.

References

  1. Moeser, A.J.; Pohl, C.S.; Rajput, M. Weaning Stress and Gastrointestinal Barrier Development: Implications for Lifelong Gut Health in Pigs. Anim. Nutr. 2017, 3, 313–321. [Google Scholar] [CrossRef]
  2. Thomson, J.R.; Friendship, R.M. Digestive System. In Diseases of Swine; Zimmerman, J.J., Karriker, L.A., Ramirez, A., Schwartz, K.J., Stevenson, G.W., Zhang, J., Eds.; John Wiley & Sons, Inc.: Hoboken, NJ, USA, 2019; pp. 234–263. [Google Scholar]
  3. Moeser, A.J.; Klok, C.V.; Ryan, K.A.; Wooten, J.G.; Little, D.; Cook, V.L.; Blikslager, A.T. Stress Signaling Pathways Activated by Weaning Mediate Intestinal Dysfunction in the Pig. Am. J. Physiol. Gastrointest. Liver Physiol. 2007, 292, 173–181. [Google Scholar] [CrossRef] [PubMed]
  4. Gresse, R.; Chaucheyras-Durand, F.; Fleury, M.A.; Van de Wiele, T.; Forano, E.; Blanquet-Diot, S. Gut Microbiota Dysbiosis in Postweaning Piglets: Understanding the Keys to Health. Trends Microbiol. 2017, 25, 851–873. [Google Scholar] [CrossRef] [PubMed]
  5. Dubreuil, J.D.; Isaacson, R.E.; Schifferli, D.M. Animal Enterotoxigenic Escherichia coli. EcoSal Plus 2016, 7, 10–128. [Google Scholar] [CrossRef] [PubMed]
  6. Vidal, A.; Martín-Valls, G.E.; Tello, M.; Mateu, E.; Martín, M.; Darwich, L. Prevalence of Enteric Pathogens in Diarrheic and Non-Diarrheic Samples from Pig Farms with Neonatal Diarrhea in the North East of Spain. Vet. Microbiol. 2019, 237, 108419. [Google Scholar] [CrossRef] [PubMed]
  7. Molinari, B.L.D.; Possatti, F.; Lorenzetti, E.; Alfieri, A.F.; Alfieri, A.A. Unusual Outbreak of Post-Weaning Porcine Diarrhea Caused by Single and Mixed Infections of Rotavirus Groups A, B, C, and H. Vet. Microbiol. 2016, 193, 125–132. [Google Scholar] [CrossRef]
  8. Antas, M.; Woźniakowski, G. Current Status of Porcine Epidemic Diarrhoea (PED) in European Pigs. J. Vet. Res. 2019, 63, 465–470. [Google Scholar] [CrossRef] [PubMed]
  9. Valkó, A.; Bálint, Á.; Bozsa, Á.; Cságola, A. Prevalence of Antibodies against Transmissible Gastroenteritis Virus (TGEV) in Hungary. Vet. Anim. Sci. 2019, 7, 100042. [Google Scholar] [CrossRef]
  10. Rhouma, M.; Fairbrother, J.M.; Beaudry, F.; Letellier, A. Post Weaning Diarrhea in Pigs: Risk Factors and Non-Colistin-Based Control Strategies. Acta Vet. Scand. 2017, 59, 31. [Google Scholar] [CrossRef]
  11. Cameron-Veas, K.; Solà-Ginés, M.; Moreno, M.A.; Fraile, L.; Migura-Garcia, L. Impact of the Use of β-Lactam Antimicrobials on the Emergence of Escherichia coli Isolates Resistant to Cephalosporins under Standard Pig-Rearing Conditions. Appl. Environ. Microbiol. 2015, 81, 1782–1787. [Google Scholar] [CrossRef]
  12. Miguela-Villoldo, P.; Hernández, M.; Moreno, M.A.; Rodríguez-Lázaro, D.; Quesada, A.; Domínguez, L.; Ugarte-Ruiz, M. National Colistin Sales versus Colistin Resistance in Spanish Pig Production. Res. Vet. Sci. 2019, 123, 141–143. [Google Scholar] [CrossRef]
  13. Kyung-hyo, D.; Jae-won, B.; Wan-kyu, L. Antimicrobial Resistance Profiles of Escherichia coli from Diarrheic Weaned Piglets after the Ban on Antibiotic Growth Promoters in Feed. Antibiotics 2020, 9, 755. [Google Scholar] [CrossRef]
  14. Ikuta, K.S.; Swetschinski, L.R.; Robles Aguilar, G.; Sharara, F.; Mestrovic, T.; Gray, A.P.; Davis Weaver, N.; Wool, E.E.; Han, C.; Gershberg Hayoon, A.; et al. Global Mortality Associated with 33 Bacterial Pathogens in 2019: A Systematic Analysis for the Global Burden of Disease Study 2019. Lancet 2022, 400, 2221–2248. [Google Scholar] [CrossRef]
  15. Allel, K.; Day, L.; Hamilton, A.; Lin, L.; Furuya-Kanamori, L.; Moore, C.E.; Van Boeckel, T.; Laxminarayan, R.; Yakob, L. Global Antimicrobial-Resistance Drivers: An Ecological Country-Level Study at the Human–Animal Interface. Lancet Planet. Health 2023, 7, e291–e303. [Google Scholar] [CrossRef]
  16. Ludden, C.; Raven, K.E.; Jamrozy, D.; Gouliouris, T.; Blane, B.; Coll, F.; de Goffau, M.; Naydenova, P.; Horner, C.; Hernandez-Garcia, J.; et al. One Health Genomic Surveillance of Escherichia coli Demonstrates Distinct Lineages and Mobile Genetic Elements in Isolates from Humans versus Livestock. mBio 2019, 10, 10–128. [Google Scholar] [CrossRef]
  17. Thorpe, H.A.; Booton, R.; Kallonen, T.; Gibbon, M.J.; Couto, N.; Passet, V.; López-Fernández, S.; Rodrigues, C.; Matthews, L.; Mitchell, S.; et al. A Large-Scale Genomic Snapshot of Klebsiella Spp. Isolates in Northern Italy Reveals Limited Transmission between Clinical and Non-Clinical Settings. Nat. Microbiol. 2022, 7, 2054–2067. [Google Scholar] [CrossRef]
  18. Viñes, J.; Cuscó, A.; Napp, S.; Alvarez, J.; Saez-Llorente, J.L.; Rosàs-Rodoreda, M.; Francino, O.; Migura-Garcia, L. Transmission of Similar Mcr-1 Carrying Plasmids among Different Escherichia coli Lineages Isolated from Livestock and the Farmer. Antibiotics 2021, 10, 313. [Google Scholar] [CrossRef] [PubMed]
  19. Dorado-García, A.; Bos, M.E.H.; Graveland, H.; Van Cleef, B.A.G.L.; Verstappen, K.M.; Kluytmans, J.A.J.W.; Wagenaar, J.A.; Heederik, D.J.J. Risk Factors for Persistence of Livestock-Associated MRSA and Environmental Exposure in Veal Calf Farmers and Their Family Members: An Observational Longitudinal Study. BMJ Open 2013, 3, e003272. [Google Scholar] [CrossRef]
  20. Reynaga, E.; Torres, C.; Garcia-Nuñez, M.; Navarro, M.; Vilamala, A.; Puigoriol, E.; Enrico Lucchetti, G.; Nunes, D.; Silva, A.; Sabrià, M. Prevalence of MRSA ST398 Carriage in Nursing Home Residents in an Area of Spain with a High Density of Pig Farming. Infect. Control Hosp. Epidemiol. 2018, 39, 90–93. [Google Scholar] [CrossRef] [PubMed]
  21. Van Gompel, L.; Luiken, R.E.C.; Sarrazin, S.; Munk, P.; Knudsen, B.E.; Hansen, R.B.; Bossers, A.; Aarestrup, F.M.; Dewulf, J.; Wagenaar, J.A.; et al. The Antimicrobial Resistome in Relation to Antimicrobial Use and Biosecurity in Pig Farming, a Metagenome-Wide Association Study in Nine European Countries. J. Antimicrob. Chemother. 2019, 74, 865–876. [Google Scholar] [CrossRef] [PubMed]
  22. European Medicine Agency. Updated Advice on the Use of Colistin Products in Animals within the European Union: Development of Resistance and Possible Impact on Human and Animal Health; European Medicine Agency: London, UK, 2016.
  23. García, V.; Gambino, M.; Pedersen, K.; Haugegaard, S.; Olsen, J.E.; Herrero-Fresno, A. F4- and F18-Positive Enterotoxigenic Escherichia coli Isolates from Diarrhea of Postweaning Pigs: Genomic Characterization. Appl. Environ. Microbiol. 2020, 86, e01913-20. [Google Scholar] [CrossRef]
  24. Munk, P.; Knudsen, B.E.; Lukjancenko, O.; Duarte, A.S.R.; Van Gompel, L.; Luiken, R.E.C.; Smit, L.A.M.; Schmitt, H.; Garcia, A.D.; Hansen, R.B.; et al. Abundance and Diversity of the Faecal Resistome in Slaughter Pigs and Broilers in Nine European Countries. Nat. Microbiol. 2018, 3, 898–908. [Google Scholar] [CrossRef] [PubMed]
  25. Bauer, A.W.; Kirby, W.M.; Sherris, J.C.; Turck, M. Antibiotic Susceptibility Testing by a Standardized Single Disk Method. Am. J. Clin. Pathol. 1966, 45, 493–496. [Google Scholar] [CrossRef]
  26. EUCAST MIC and Zone Diameter Distributions and ECOFFs. Available online: https://www.eucast.org/mic_and_zone_distributions_and_ecoffs (accessed on 29 January 2024).
  27. CASFM Comité de l’Antibiogramme de La Société Française de Microbiologie Recommandations 2020. Com. L’Antibiogramme Société Française Microbiol. 2020, 86. Available online: https://www.sfm-microbiologie.org/wp-content/uploads/2020/04/CASFM2020_Avril2020_V1.1.pdf (accessed on 29 January 2024).
  28. CLSI. Performance Standards for Antimicrobial Disk and Dilution Susceptibility Tests for Bacteria Isolated from Animals, 4th ed.; CLSI Supplement VET08; Clinical and Laboratory Standards Institute: Wayne, PA, USA, 2018. [Google Scholar]
  29. Abmm, D.; Tamma, D.; Kirn, J.; Cullen, S.K. Clinical and Laboratory Standards Institute (CLSI). Performance Standards for Antimicrobial Susceptibility Testing, 30th ed.; CLSI supplement M100; Clinical and Laboratory Standards Institute: Wayne, PA, USA, 2020. [Google Scholar]
  30. Vidal, A.; Aguirre, L.; Seminati, C.; Tello, M.; Redondo, N.; Martín, M.; Darwich, L. Antimicrobial Resistance Profiles and Characterization of Escherichia coli Strains from Cases of Neonatal Diarrhea in Spanish Pig Farms. Vet. Sci. 2020, 7, 48. [Google Scholar] [CrossRef] [PubMed]
  31. Magiorakos, A.-P.; Srinivasan, A.; Carey, R.B.; Carmeli, Y.; Falagas, M.E.; Giske, C.G.; Harbarth, S.; Hindler, J.F.; Kahlmeter, G.; Olsson-Liljequist, B.; et al. Multidrug-Resistant, Extensively Drug-Resistant and Pandrug-Resistant Bacteria: An International Expert Proposal for Interim Standard Definitions for Acquired Resistance. Clin. Microbiol. Infect. 2012, 18, 268–281. [Google Scholar] [CrossRef]
  32. R Core Team. R: A Language and Environment for Statistical Computing; R Foundation for Statistical Computing: Vienna, Austria, 2020. [Google Scholar]
  33. Wickham, H. Ggplot2. Wiley Interdiscip. Rev. Comput. Stat. 2011, 3, 180–185. [Google Scholar] [CrossRef]
  34. Jansen, W.; van Hout, J.; Wiegel, J.; Iatridou, D.; Chantziaras, I.; De Briyne, N. Colistin Use in European Livestock: Veterinary Field Data on Trends and Perspectives for Further Reduction. Vet. Sci. 2022, 9, 650. [Google Scholar] [CrossRef]
  35. Renzhammer, R.; Loncaric, I.; Roch, F.-F.; Pinior, B.; Käsbohrer, A.; Spergser, J.; Ladinig, A.; Unterweger, C. Prevalence of Virulence Genes and Antimicrobial Resistances in E. coli Associated with Neonatal Diarrhea, Postweaning Diarrhea, and Edema Disease in Pigs from Austria. Antibiotics 2020, 9, 208. [Google Scholar] [CrossRef] [PubMed]
  36. Aguirre, L.; Vidal, A.; Seminati, C.; Tello, M.; Redondo, N.; Darwich, L.; Martín, M. Antimicrobial Resistance Profile and Prevalence of Extended-Spectrum Beta-Lactamases (ESBL), AmpC Beta-Lactamases and Colistin Resistance (Mcr) Genes in Escherichia coli from Swine between 1999 and 2018. Porcine Health Manag. 2020, 6, 4–9. [Google Scholar] [CrossRef]
  37. Peng, Z.; Hu, Z.; Li, Z.; Zhang, X.; Jia, C.; Li, T.; Dai, M.; Tan, C.; Xu, Z.; Wu, B.; et al. Antimicrobial Resistance and Population Genomics of Multidrug-Resistant Escherichia coli in Pig Farms in Mainland China. Nat. Commun. 2022, 13, 1116. [Google Scholar] [CrossRef] [PubMed]
  38. Jiang, F.; Wu, Z.; Zheng, Y.; Frana, T.S.; Sahin, O.; Zhang, Q.; Li, G. Genotypes and Antimicrobial Susceptibility Profiles of Hemolytic Escherichia coli from Diarrheic Piglets. Foodborne Pathog. Dis. 2019, 16, 94–103. [Google Scholar] [CrossRef] [PubMed]
  39. Yun, J.; Muurinen, J.; Nykäsenoja, S.; Seppä-Lassila, L.; Sali, V.; Suomi, J.; Tuominen, P.; Joutsen, S.; Hämäläinen, M.; Olkkola, S.; et al. Antimicrobial Use, Biosecurity, Herd Characteristics, and Antimicrobial Resistance in Indicator Escherichia coli in Ten Finnish Pig Farms. Prev. Vet. Med. 2021, 193, 105408. [Google Scholar] [CrossRef] [PubMed]
  40. Smith, M.G.; Jordan, D.; Chapman, T.A.; Chin, J.J.C.; Barton, M.D.; Do, T.N.; Fahy, V.A.; Fairbrother, J.M.; Trott, D.J. Antimicrobial Resistance and Virulence Gene Profiles in Multi-Drug Resistant Enterotoxigenic Escherichia coli Isolated from Pigs with Post-Weaning Diarrhoea. Vet. Microbiol. 2010, 145, 299–307. [Google Scholar] [CrossRef]
  41. Dewulf, J.; Joosten, P.; Chantziaras, I.; Bernaerdt, E.; Vanderhaeghen, W.; Postma, M.; Maes, D. Antibiotic Use in European Pig Production: Less Is More. Antibiotics 2022, 11, 1493. [Google Scholar] [CrossRef]
  42. Gao, J.; Yin, J.; Xu, K.; Li, T.; Yin, Y. What Is the Impact of Diet on Nutritional Diarrhea Associated with Gut Microbiota in Weaning Piglets: A System Review. Biomed. Res. Int. 2019, 2019, 6916189. [Google Scholar] [CrossRef]
  43. Dorado-García, A.; Graveland, H.; Bos, M.E.H.; Verstappen, K.M.; Van Cleef, B.A.G.L.; Kluytmans, J.A.J.W.; Wagenaar, J.A.; Heederik, D.J.J. Effects of Reducing Antimicrobial Use and Applying a Cleaning and Disinfection Program in Veal Calf Farming: Experiences from an Intervention Study to Control Livestock-Associated MRSA. PLoS ONE 2015, 10, e0139536. [Google Scholar] [CrossRef]
  44. Correa, F.; Luise, D.; Amatucci, L.; Palumbo, F.; Virdis, S.; Negrini, C.; Clavenzani, P.; Vecchi, M.; Mazzoni, M.; Bosi, P.; et al. Effect of an Escherichia coli F4/F18 Bivalent Oral Live Vaccine on Gut Health and Performance of Healthy Weaned Pigs. Animal 2022, 16, 654. [Google Scholar] [CrossRef]
  45. Luise, D.; Bertocchi, M.; Motta, V.; Salvarani, C.; Bosi, P.; Luppi, A.; Fanelli, F.; Mazzoni, M.; Archetti, I.; Maiorano, G.; et al. Bacillus Sp. Probiotic Supplementation Diminish the Escherichia coli F4ac Infection in Susceptible Weaned Pigs by Influencing the Intestinal Immune Response, Intestinal Microbiota and Blood Metabolomics. J. Anim. Sci. Biotechnol. 2019, 10, 74. [Google Scholar] [CrossRef]
  46. Lee, C.Y.; Kim, S.J.; Park, B.C.; Han, J.H. Effects of Dietary Supplementation of Bacteriophages against Enterotoxigenic Escherichia coli (ETEC) K88 on Clinical Symptoms of Post-Weaning Pigs Challenged with the ETEC Pathogen. J. Anim. Physiol. Anim. Nutr. 2017, 101, 88–95. [Google Scholar] [CrossRef]
  47. Lecce, J.G.; Balsbaugh, R.K.; Clare, D.A.; King, M.W. Rotavirus and Hemolytic Enteropathogenic Escherichia coli in Weanling Diarrhea of Pigs. J. Clin. Microbiol. 1982, 16, 715–723. [Google Scholar] [CrossRef]
  48. Vlasova, A.N.; Wang, Q.; Jung, K.; Langel, S.N.; Malik, Y.S.; Saif, L.J. Porcine Coronaviruses. In Emerging and Transboundary Animal Viruses; Springer: Singapore, 2020; pp. 79–110. ISBN 978-981-15-0401-3. [Google Scholar]
  49. Mulchandani, R.; Wang, Y.; Gilbert, M.; Van Boeckel, T.P. Global Trends in Antimicrobial Use in Food-Producing Animals: 2020 to 2030. PLoS Glob. Public Health 2023, 3, e0001305. [Google Scholar] [CrossRef]
  50. Byarugaba, D.K.; Wokorach, G.; Alafi, S.; Erima, B.; Najjuka, F.; Mworozi, E.A.; Kibuuka, H.; Wabwire-Mangen, F. Whole Genome Sequencing Reveals High Genetic Diversity, Diverse Repertoire of Virulence-Associated Genes and Limited Antibiotic Resistance Genes among Commensal Escherichia coli from Food Animals in Uganda. Microorganisms 2023, 11, 1868. [Google Scholar] [CrossRef]
  51. Zingali, T.; Reid, C.J.; Chapman, T.A.; Gaio, D.; Liu, M.; Darling, A.E.; Djordjevic, S.P. Whole Genome Sequencing Analysis of Porcine Faecal Commensal Escherichia coli Carrying Class 1 Integrons from Sows and Their Offspring. Microorganisms 2020, 8, 843. [Google Scholar] [CrossRef]
  52. Edgar, R.; Bibi, E. MdfA, an Escherichia coli Multidrug Resistance Protein with an Extraordinarily Broad Spectrum of Drug Recognition. J. Bacteriol. 1997, 179, 2274–2280. [Google Scholar] [CrossRef] [PubMed]
  53. Hayer, S.S.; Casanova-Higes, A.; Paladino, E.; Elnekave, E.; Nault, A.; Johnson, T.; Bender, J.; Perez, A.; Alvarez, J. Global Distribution of Fluoroquinolone and Colistin Resistance and Associated Resistance Markers in Escherichia coli of Swine Origin—A Systematic Review and Meta-Analysis. Front. Microbiol. 2022, 13, 834793. [Google Scholar] [CrossRef] [PubMed]
  54. Shen, Y.; Zhou, H.; Xu, J.; Wang, Y.; Zhang, Q.; Walsh, T.R.; Shao, B.; Wu, C.; Hu, Y.; Yang, L.; et al. Anthropogenic and Environmental Factors Associated with High Incidence of Mcr-1 Carriage in Humans across China. Nat. Microbiol. 2018, 3, 1054–1062. [Google Scholar] [CrossRef] [PubMed]
  55. ESVAC. Spain—Sales and Trends (Mg/PCU) of Antibiotic VMPs for Food-Producing Animals; European Medicine Agency: London, UK, 2023.
  56. Ogunlana, L.; Kaur, D.; Shaw, L.P.; Jangir, P.; Walsh, T.; Uphoff, S.; MacLean, R.C. Regulatory Fine-Tuning of Mcr-1 Increases Bacterial Fitness and Stabilises Antibiotic Resistance in Agricultural Settings. ISME J. 2023, 17, 2058–2069. [Google Scholar] [CrossRef]
  57. Tsekouras, N.; Athanasakopoulou, Z.; Diezel, C.; Kostoulas, P.; Braun, S.D.; Sofia, M.; Monecke, S.; Ehricht, R.; Chatzopoulos, D.C.; Gary, D.; et al. Cross-Sectional Survey of Antibiotic Resistance in Extended Spectrum Β-Lactamase-Producing Enterobacteriaceae Isolated from Pigs in Greece. Animals 2022, 12, 1560. [Google Scholar] [CrossRef]
  58. Diaconu, E.L.; Carfora, V.; Alba, P.; Di Matteo, P.; Stravino, F.; Buccella, C.; Dell’Aira, E.; Onorati, R.; Sorbara, L.; Battisti, A.; et al. Novel IncFII Plasmid Harbouring BlaNDM-4 in a Carbapenem-Resistant Escherichia coli of Pig Origin, Italy. J. Antimicrob. Chemother. 2020, 75, 3475–3479. [Google Scholar] [CrossRef]
  59. Nirupama, K.R.; Vinodh, V.K.; Pruthvishree, B.S.; Sinha, D.K.; Murugan, M.S.; Krishnaswamy, N.; Singh, B.R. Molecular Characterisation of BlaOXA-48 Carbapenemase-, Extended-Spectrum β-Lactamase- and Shiga Toxin-Producing Escherichia coli Isolated from Farm Piglets in India. J. Glob. Antimicrob. Resist. 2018, 13, 201–205. [Google Scholar] [CrossRef] [PubMed]
  60. Garcia, P.G.; Silva, V.L.; Diniz, C.G. Occurrence and Antimicrobial Drug Susceptibility Patterns of Commensal and Diarrheagenic Escherichia coli in Fecal Microbiota from Children with and without Acute Diarrhea. J. Microbiol. 2011, 49, 46–52. [Google Scholar] [CrossRef] [PubMed]
Figure 1. Percentage of antimicrobial resistance in E. coli isolates (n = 251). AM: Amoxicillin; AMC: Amoxicillin + Clavulanic Acid; CEX: Cephalexin; CTF: Ceftiofur; IMP: Imipenem; COL: Colistin; ENR: Enrofloxacin; FFC: Florfenicol; ERY: Erythromycin; GEN: Gentamycin; STR: Streptomycin; LS: Lincospectin; SXT: sulfamethoxazole/trimethoprim; TET: Tetracycline.
Figure 1. Percentage of antimicrobial resistance in E. coli isolates (n = 251). AM: Amoxicillin; AMC: Amoxicillin + Clavulanic Acid; CEX: Cephalexin; CTF: Ceftiofur; IMP: Imipenem; COL: Colistin; ENR: Enrofloxacin; FFC: Florfenicol; ERY: Erythromycin; GEN: Gentamycin; STR: Streptomycin; LS: Lincospectin; SXT: sulfamethoxazole/trimethoprim; TET: Tetracycline.
Animals 14 00487 g001
Figure 2. Comparison of antibiotic resistance levels between diarrheic (n = 148) and apparently healthy (n = 103) animals. AM: Amoxicillin; AMC: Amoxicillin + Clavulanic Acid; CEX: Cephalexin; CTF: Ceftiofur; IMP: Imipenem; COL: Colistin; ENR: Enrofloxacin; FFC: Florfenicol; ERY: Erythromycin; GEN: Gentamycin; STR: Streptomycin; LS: Lincospectin; SXT: sulfamethoxazole/trimethoprim; TET: Tetracycline. Red: diarrheic animals; blue: healthy animals. * p < 0.05.
Figure 2. Comparison of antibiotic resistance levels between diarrheic (n = 148) and apparently healthy (n = 103) animals. AM: Amoxicillin; AMC: Amoxicillin + Clavulanic Acid; CEX: Cephalexin; CTF: Ceftiofur; IMP: Imipenem; COL: Colistin; ENR: Enrofloxacin; FFC: Florfenicol; ERY: Erythromycin; GEN: Gentamycin; STR: Streptomycin; LS: Lincospectin; SXT: sulfamethoxazole/trimethoprim; TET: Tetracycline. Red: diarrheic animals; blue: healthy animals. * p < 0.05.
Animals 14 00487 g002
Figure 3. (A): Histogram showing the colistin minimum inhibitory concentration. Green: susceptible. Orange: intermediate. Red: resistant. The vertical lines represent percentiles 50 and 90 of minimum inhibitory concentration. (B): Density plot of MIC distribution comparing healthy and diarrheic animals. Red line: MIC90 of diarrheic piglets. Blue line: MIC90 of healthy piglets.
Figure 3. (A): Histogram showing the colistin minimum inhibitory concentration. Green: susceptible. Orange: intermediate. Red: resistant. The vertical lines represent percentiles 50 and 90 of minimum inhibitory concentration. (B): Density plot of MIC distribution comparing healthy and diarrheic animals. Red line: MIC90 of diarrheic piglets. Blue line: MIC90 of healthy piglets.
Animals 14 00487 g003
Table 1. Comparison of resistance frequency between apparently healthy and diarrheic piglets for each antibiotic.
Table 1. Comparison of resistance frequency between apparently healthy and diarrheic piglets for each antibiotic.
ClassAntimicrobial% Resistant
Apparently HealthyDiarrheicTotal
PenicillinAmoxicillin93.391.492.1
Penicillin + betalactamase inhibitorAmoxicillin + clavulanic acid29.131.831.7
1st generation cephalosporinCephalexin15.947.835.1
3rd generation cephalosporinCeftiofur22.232.627.7
CarbapenemImipenem0.00.00.0
PolymyxinsColistin11.517.715.0
QuinolonesEnrofloxacin55.557.556.7
PhenicolsFlorfenicol46.644.645.4
MacrolideErythromycin99.0100.099.6
AminoglycosideGentamycin34.033.133.5
AminoglycosideStreptomycin93.290.591.6
AminoglycosideLincospectin59.766.263.1
Trimethoprim + sulfamideTrimethoprim + sulphametoxazole56.560.258.7
TetracyclineTetracycline90.387.988.8
Disclaimer/Publisher’s Note: The statements, opinions and data contained in all publications are solely those of the individual author(s) and contributor(s) and not of MDPI and/or the editor(s). MDPI and/or the editor(s) disclaim responsibility for any injury to people or property resulting from any ideas, methods, instructions or products referred to in the content.

Share and Cite

MDPI and ACS Style

Garcias, B.; Martin, M.; Darwich, L. Characterization of Antimicrobial Resistance in Escherichia coli Isolated from Diarrheic and Healthy Weaned Pigs in Catalonia. Animals 2024, 14, 487. https://0-doi-org.brum.beds.ac.uk/10.3390/ani14030487

AMA Style

Garcias B, Martin M, Darwich L. Characterization of Antimicrobial Resistance in Escherichia coli Isolated from Diarrheic and Healthy Weaned Pigs in Catalonia. Animals. 2024; 14(3):487. https://0-doi-org.brum.beds.ac.uk/10.3390/ani14030487

Chicago/Turabian Style

Garcias, Biel, Marga Martin, and Laila Darwich. 2024. "Characterization of Antimicrobial Resistance in Escherichia coli Isolated from Diarrheic and Healthy Weaned Pigs in Catalonia" Animals 14, no. 3: 487. https://0-doi-org.brum.beds.ac.uk/10.3390/ani14030487

Note that from the first issue of 2016, this journal uses article numbers instead of page numbers. See further details here.

Article Metrics

Back to TopTop